Abstract
Data coming from the literature investigating the effectiveness and interaction between smoking cessation (SC) and lung cancer screening (LCScr) are still sparse and inconsistent. Herein, we report the preliminary results from the ongoing lung cancer screening trial (“Cosmos-II”) focusing our analysis on the inter-relationship between the SC program and the LCScr.
This is a preview of subscription content, log in via an institution to check access.
References
Centers for Disease Control and Prevention. Lung cancer: risk factors. http://www.cdc.gov/cancer/lung/basic_info/risk_factors.htm. Accessed July 2013
US Department of Health and Human Services, Centers for Disease Control and Prevention and Health Promotion, Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Washington, DC: USDHSS; 2014.2
US Department of Health and Human Services (2008) Treating tobacco use and dependence: 2008 update. USDHHS, Rockville
Deppen SA, Grogan EL, Aldrich MC, Massion PP (2014) Lung cancer screening and smoking cessation: a teachable moment? J Natl Cancer Inst 106(6):dju122. doi:10.1093/jnci/dju122 No abstract available
Joseph AM, Fu SS, Lindgren B et al (2011) Chronic disease management for tobacco dependence: a randomized, controlled trial. Arch Intern Med 171(21):1894–1900
National Comprehensive Cancer Network. Lung Cancer Screening v1.2014. NCCN Clinical Practice Guidelines in Oncology, 2014. http://www.nccn.org/professionals/physician_gls/recently_updated.asp. Accessed April 17 2014
Field JK, Smith RA, Aberle DR et al (2012) International association for the study of lung cancer computed tomography screening workshop 2011 report. J Thorac Oncol 7(1):10–19
Ferketich AK, Otterson GA, King M, Hall N, Browning KK, Wewers ME (2012) A pilot test of a combined tobacco dependence treatment and lung cancer screening program. Lung Cancer 76(2):211–215. doi:10.1016/j.lungcan.2011.10.011.Epub
Fagerstrőm KO, Schneirder NG (1989) Measuring nicotine dependence: a review of the Fagerstrőm Tolerance Questionnaire. J Behav Med 12:159–182
Gallus S, Tramacere I, La Vecchia C, Colombo P, Zuccaro P, Paleari L, Cesario A, Russo P, Apolone G (2009) Use of pharmacotherapy for smoking cessation in Italy. Arch Intern Med 169(20):1927–1928. doi:10.1001/archinternmed.2009.354 PubMed PMID: 19901149
Munshi V, McMahon P (2013) Importance of smoking cessation in a lung cancer screening program. Curr Surg Rep 1(4):242–248. doi:10.1007/s40137-013-0030-1
van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ (2010) Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch–Belgian randomised controlled lung cancer screening trial. Thorax 65(7):600–605. doi:10.1136/thx.2009.133751
Acknowledgment
We thank AIRC to support the “Cosmos-II Trial”.
Disclosure
Filippo Lococo and Francesco Carleo have received Grant support as “Young Investigator” from the “Umberto Veronesi Foundation”. The other Authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Filippo, L., Principe, R., Cesario, A. et al. Smoking Cessation Intervention Within the Framework of a Lung Cancer Screening Program: Preliminary Results and Clinical Perspectives from the “Cosmos-II” Trial. Lung 193, 147–149 (2015). https://doi.org/10.1007/s00408-014-9661-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-014-9661-y